secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO KEY INTERNATIONAL INC (BKYI)
CIK:        0001019034
Form:       8-K
Filed at:   2024-06-14T23:59:59+00:00
Accession:  0001437749-24-020367
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

BIO-key receives Nasdaq delisting notice for stockholders' equity below $2.5M
-----------------------------------------------------------------------------

- Nasdaq notified BIO-key on June 10, 2024 that stockholders' equity as of Dec 31, 2023 failed to meet the $2.5M minimum requirement.
- Company has 45 calendar days, until July 25, 2024, to submit a plan to regain compliance.
- If Nasdaq accepts the plan, it may grant an extension of up to 180 calendar days from the notice date.
- If plan is not accepted or compliance not regained, BIO-key may request a hearing; delisting action stayed during hearing.
- No assurance that the company will be able to regain compliance with the continued listing rule.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1019034/000143774924020367/0001437749-24-020367-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1019034/000143774924020367/bkyi20240613_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-020367

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer